Accessibility Menu
 
ImmuCell logo

ImmuCell

(NASDAQ) ICCC

Current Price$6.32
Market Cap$55.63M
Since IPO (1992)+515%
5 Year-45%
1 Year+28%
1 Month-1%

ImmuCell Financials at a Glance

Market Cap

$55.63M

Revenue (TTM)

$27.64M

Net Income (TTM)

$1.04M

EPS (TTM)

$-0.11

P/E Ratio

-54.09

Dividend

$0.00

Beta (Volatility)

0.22 (Low)

Price

$6.32

Volume

0

Open

$6.04

Previous Close

$6.32

Daily Range

$6.04 - $6.32

52-Week Range

$4.52 - $7.60

ICCC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ImmuCell

Industry

Biotechnology

Employees

75

CEO

Olivier te Boekhorst

Headquarters

Portland, ME 04103, US

ICCC Financials

Key Financial Metrics (TTM)

Gross Margin

41%

Operating Margin

6%

Net Income Margin

-4%

Return on Equity

-4%

Return on Capital

4%

Return on Assets

-2%

Earnings Yield

-1.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$55.63M

Shares Outstanding

9.05M

Volume

0

Short Interest

0.00%

Avg. Volume

24.11K

Financials (TTM)

Gross Profit

$11.45M

Operating Income

$1.65M

EBITDA

$4.43M

Operating Cash Flow

$0.00

Capital Expenditure

$0.00

Free Cash Flow

$0.00

Cash & ST Invst.

$3.81M

Total Debt

$0.00

ImmuCell Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$7.63M

-1.6%

Gross Profit

$2.91M

+2.8%

Gross Margin

38.16%

N/A

Market Cap

$55.63M

N/A

Market Cap/Employee

$806.26K

N/A

Employees

69

N/A

Net Income

$2.85M

-653.7%

EBITDA

$652.00K

-50.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$3.81M

+133.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$9.27M

+30.3%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-2.44%

N/A

Return on Invested Capital

3.88%

N/A

Free Cash Flow

$914.62K

-359.0%

Operating Cash Flow

$1.99M

-65214.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OSTXOS Therapies Incorporated
$1.49-1.00%
COEPCoeptis Therapeutics, Inc.
$10.97-2.92%
EQEquillium, Inc.
$2.15+0.23%
NRXPNRx Pharmaceuticals, Inc.
$1.81-1.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
SMCISuper Micro Computer
$20.95-0.32%
TQQQProShares Trust - ProShares UltraPro Qqq
$42.95-0.06%
ANNAAleAnna
$6.95+0.83%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.78+0.06%

Questions About ICCC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.